(2) hours on controlled substance prescribing practices, recognizing signs of the abuse or misuse of controlled substances, or controlled substance prescribing for pain management (for ASCS registrants).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.albme.gov/resources/licensees/continuing-medical-education/qacsc-cme-requirement.

(12) hours on controlled substance prescribing practices and pharmacology (initial QACSC registrant);
(4) hours on advanced pharmacology and prescribing trends (through Board-approved course).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.abn.alabama.gov/licensing/advanced-practice/ 
https://www.albme.gov/licensing/crnp-cnm/qacsc/

(8) hours on controlled substance prescribing practices and pharmacology (through Board-specified course, for initial QASCS registrants);
(4) hours on advanced pharmacology and prescribing trends (through Board-approved course).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.albme.gov/resources/licensees/continuing-medical-education/qacsc-cme-requirement

(2) hours on pain management and opioid use and addiction (for DEA registration).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.commerce.alaska.gov/FrequentlyAskedQuestions.aspx#continuingEd

(2) hours on pain management and opioid use and addiction (for DEA registration; the title on Certificate should specifically reference all three areas of the required subject matter: pain management, opioid use, and addiction).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.commerce.alaska.gov/web/Portals/5/pub/NursingStatutes.pdf

(2) hours on pain management and opioid use and addiction (for DEA registration).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.commerce.alaska.gov/web/cbpl/ProfessionalLicensing/StateMedicalBoard/FrequentlyAskedQuestions.aspx#continuingEd 

(3) hours on opioids, substance use disorder, or addiction (for those with DEA license).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://azmd.gov/Home/Index/#top 

(3) hours on opioids, substance use disorder, or addiction (for those with DEA license).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.azbn.gov/laws-and-rules/prescribing-requirements

(3) hours on opioids, substance use disorder, or addiction (for those with DEA license).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://azpa.gov/Licensure/Licensure/pa-renewal-opioid-cme

1 credit on prescribing opioids and/or benzodiazepines;
50% of CME hours must be in the physician's primary area of practice.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.healthy.arkansas.gov/programs-services/topics/arkansas-state-medical-board

All APRNs issued a certificate of prescriptive authority after December 31, 2015, shall obtain a minimum of three (3) hours of prescribing education which includes information on maintaining professional boundaries and the prescribing rules, regulations, and laws that apply to APRNs in the state within two (2) years of issuance of the prescriptive authority certificate (ASBN Rules, Chapter 4, Section VIII, A.7.). In order to meet this requirement, you will need to complete two courses, Advanced Practice Nursing in Arkansas (2 contact hours) and Prescription Drug Misuse and Abuse (1 contact hour).

(5) hours each biennium in pharmacotherapeutics in the APRN’s area of certification (for those with prescriptive authority);
(2) of these prescribing hours must contain information related to maintaining professional boundaries and the prescribing rules, regulations, and laws that apply to APRNs in Arkansas (ASBN Rules, Chapter 4, Section III,F.7.). In order to meet this requirement, you will need to complete the course Advanced Practice Nursing in Arkansas (2 contact hours).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.healthy.arkansas.gov/programs-services/topics/arsbn-adv.-practice

(5) hours on pain management (if authorized to prescribe Schedule II hydrocodone combination products reclassified from Schedule 3 to Schedule 2);
(1) hour on prescribing of opioids and benzodiazepines.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.healthy.arkansas.gov/programs-services/topics/arkansas-state-medical-board
https://casetext.com/regulation/arkansas-administrative-code/agency-007-arkansas-department-of-health/division-33-division-of-health-related-boards-and-commissions/rule-0073322-010-rule-24-physician-assistants

(12) hours of CME on pain management and the appropriate care and treatment of the terminally ill (one-time requirement to be completed by 2nd license renewal, or within four years).
The 12 units may be divided in any way that is relevant to the physician's specialty and practice setting, and must also include the risks of addiction associated with the use of Schedule II drugs. As an alternative, a physician may complete a one-time CE course of 12 credit hours in the subjects of treatment and management of opiate-dependent patients, including 8 hours of training in buprenorphine treatment or other similar medicinal treatment for opioid use disorders (to be completed by next license renewal date after licensure).

General internists and family physicians who have a patient population of which over 25 percent are 65 years of age or older: 20% of CME must be in geriatric medicine, the special care needs of patients with dementia, or the care of older patients.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
www.mbc.ca.gov/Licensees/Continuing_Education/
https://www.ombc.ca.gov

(1) hour on implicit bias, from BRN-approved provider (within first 2 years).

A nurse practitioner who provides primary care to a patient population of which over 25 percent are 65 years of age or older:  at least 20% of CE hours must be in the field of gerontology, the special care needs of patients with dementia, or the care of older patients (NEW, approved in 2024). 

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.rn.ca.gov/licensees/ce-renewal.shtml#implicitbias

A physician assistant who provides primary care to a patient population of which over 25 percent are 65 years of age or older: at least 20% of CME must be in the field of gerontology, the special care needs of patients with dementia, or the care of older patients (NEW, approved in 2024).  

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.pab.ca.gov/licensees/cmeregs.shtml

(2) hours on substance use prevention.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.sos.state.co.us/CCR/GenerateRulePdf.do?fileName=3+CCR+713-44&ruleVersionId=8594&utm_medium=email&utm_source=govdelivery

(2) hours on substance use prevention.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dpo.colorado.gov/Nursing

(2) hours on substance use prevention.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.sos.state.co.us/CCR/GenerateRulePdf.do?fileName=3+CCR+713-44&ruleVersionId=8594&utm_medium=email&utm_source=govdelivery

(1) hour on infectious diseases, including acquired immune deficiency syndrome and HIV;
(1) hour on risk management, including prescribing controlled substances and pain management;
(1) hour on sexual assault;
(1) hour on domestic violence;
(1) hour on cultural competency;
(2) hours on behavioral health, including mental health conditions common to veterans and family members of veterans, including (i) determining whether a patient is a veteran or family member of a veteran, (ii) screening for conditions such as post-traumatic stress disorder, risk of suicide, depression and grief, and (iii) suicide prevention training (with first renewal, and every six years).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://portal.ct.gov/DPH/Practitioner-Licensing--Investigations/Physician/Continuing-Medical-Education

(1) hour on diseases, including acquired immune deficiency syndrome and HIV;
(1) hour on risk management;
(1) hour on sexual assault;
(1) hour on domestic violence;
(1) hour on cultural competency;
(1) hour on substance abuse, including prescribing controlled substances and pain management;
(2) hours on mental health conditions common to veterans and family members of veterans (with first renewal, and every six years).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://portal.ct.gov/DPH/Practitioner-Licensing--Investigations/APRN/Continuing-Education

(1) hour on prescribing controlled substances and pain management.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://portal.ct.gov/DPH/Practitioner-Licensing--Investigations/Physician-Assistant/Continuing-Education

(2) hours on LGBTQ cultural competency;
(5) hours on a topic designated as a public health priority;
(1) course on the subject of pharmacology.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dchealth.dc.gov/bomed

(2) hours in LGBTQ or Cultural Awareness;
(3) hours in HIV/AIDS or Director's Topics.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dchealth.dc.gov/node/1163176

(2) hours on LGBTQ cultural competency;
(10) hours on a topic designated as a public health priority.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dchealth.dc.gov/bomed

(2) credits on controlled substance prescribing practices, treatment of pain management, or other topics related to the prescribing of controlled substances.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
http://regulations.delaware.gov/AdminCode/title24/Uniform Controlled Substances Act Regulations.shtml

(2) hours on controlled substance prescribing practices, treatment of pain management, or other topics related to the prescribing of controlled substances.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
http://regulations.delaware.gov/AdminCode/title24/Uniform Controlled Substances Act Regulations.shtml

(2) credits on controlled substance prescribing practices, treatment of pain management, or other topics related to the prescribing of controlled substances.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
http://regulations.delaware.gov/AdminCode/title24/Uniform Controlled Substances Act Regulations.shtml

MD:
(2) hours on Prevention of Medical Errors, to include information regarding the 5 most mis-diagnosed conditions, in accordance with Rule 64B8-13.005, F.A.C.;
(1) hour on HIV/AIDS (first renewal only);
(2) hours on Domestic Violence (every third renewal);
(2) hours on Prescribing Controlled Substances (if registered with the DEA and authorized to prescribe controlled substances), from Board-approved CME organization.

For more information:
https://flboardofmedicine.gov/renewals/medical-doctor-unrestricted/#tab-cme

DO - Additional Requirement:
(1) hour on Florida Laws

For more information:
https://floridasosteopathicmedicine.gov/renewals/#tab-ce

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

(2) hours on Prevention of Medical Errors (course must be Board approved);
(2) hours on FL Nursing Laws (course must be Board approved);
(2) hours on Human Trafficking;
(1) hour on HIV/AIDS (one-time requirement prior to first renewal, Board-approved courses);
(2) hours on Domestic Violence (every third renewal, course must be Board approved);
(2) hours on Recognizing Workplace Impairment (every 4 years);
(3) hours on Safe and Effective Prescription of Controlled Substances, from Board-approved CME/CE organization.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://floridasnursing.gov/renewals/advanced-practice-registered-nurse/

(2) hours on Prevention of Medical Errors;
(2) hours on Domestic Violence (every third renewal);
(1) hour on HIV/AIDS (first renewal only);
(3) hours on Safe and Effective Prescribing of Controlled Substances (from a board-approved CME/CE organization).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://flboardofmedicine.gov/renewals/physician-assistants/#tab-cme

(3) hours on controlled substance prescribing practices (one-time requirement for controlled substance prescribers);
(2) hours on professional boundaries and physician sexual misconduct (one-time requirement);
(20) hours on pain management or palliative medicine (for physicians who work in a pain clinic, and don't hold a certification in pain management or palliative medicine).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://medicalboard.georgia.gov/professional-resources/continuing-education-and-other-required-training-physicians

The Georgia Board of Nursing does not require any topic-specific CE.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://sos.ga.gov/georgia-board-nursing

(3) hours of continuing education in practice specific pharmaceuticals in which the physician assistant has prescription order privileges.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://medicalboard.georgia.gov/professionals/applications-center/physician-anesthesiologist-assistant-pas-and-aas

No topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://cca.hawaii.gov/pvl/boards/medical/medical-continuing-education-and-random-audit-information/

No topic-specific CE required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://cca.hawaii.gov/pvl/boards/nursing/

No topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://cca.hawaii.gov/pvl/boards/medical/medical-continuing-education-and-random-audit-information/

No topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dopl.idaho.gov/bom/

No topic-specific CE required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dopl.idaho.gov/bon/

No topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dopl.idaho.gov/bom/

(1) hour on safe opioid prescribing practices (every six years);
(1) hour on Alzheimer’s disease and other dementias (every six years);
(1) hour on implicit bias (every three years);
(1) hour on sexual harassment prevention (every three years);
(1) hour on cultural competency (every six years);
Identifying and reporting child abuse (once every six years).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://idfpr.illinois.gov/profs/physicians.html
https://www.isms.org/cme/medical-license/license-requirements

(20) hours on pharmacotherapeutics, including (10) hours of opioid prescribing or substance abuse education;
(3) hours on safe opioid prescribing practices (for prescribers with CSR); for renewals beginning on January 1, 2025, this act is amended to require (1) hour on safe opioid prescribing practices;
(1) hour on Alzheimer’s disease and other dementias (for those with direct patient interaction with adults age 26 and above);
(1) hour on implicit bias; 
(1) hour on sexual harassment prevention;
(1) hour on cultural competency (for renewals on or after January 1, 2025, and to be completed within 3 biennial renewal periods);
Identifying and reporting child abuse (once every six years)

(3) hours on safe opioid prescribing practices (for prescribers with CSR); for renewals beginning on January 1, 2025, this act is amended to require (1) hour on safe opioid prescribing practices;
(1) hour on Alzheimer’s disease and other dementias (for those with direct patient interaction with adults age 26 and above);
(1) hour on implicit bias; 
(1) hour on sexual harassment prevention;
Identifying and reporting child abuse (once every six years)
(1) hour on cultural competency (for renewals on or after January 1, 2025, and to be completed within 3 biennial renewal periods).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://idfpr.illinois.gov/profs/physicianassistant.html

(2) hours on opioid prescribing and opioid abuse (for CSR renewal).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.in.gov/pla/professions/medical-physicians-and-osteopathic-physicians-home/medical-board/
https://www.in.gov/pla/professions/indiana-controlled-substances-advisory-committee/application-and-information/registration-application/

(2) hours on opioid prescribing and opioid abuse (for CSR renewal).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.in.gov/pla/professions/nursing-home/nursing-licensing-information/#Continuing_Education_Requirement_for_CSR
https://www.in.gov/pla/professions/indiana-controlled-substances-advisory-committee/application-and-information/registration-application/

(2) hours on opioid prescribing and opioid abuse (for CSR renewal).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.in.gov/pla/professions/physician-assistant-home/
https://www.in.gov/pla/professions/indiana-controlled-substances-advisory-committee/application-and-information/registration-application/

(2) hours on the US CDC guideline for prescribing opioids for chronic pain, including recommendations on limitations on dosages and the length of prescriptions, risk factors for abuse, and nonopioid and nonpharmacologic therapy options (for licensees who have prescribed opioids during the previous license period);
(2) hours on end-of-life care.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dial.iowa.gov/i-need/licenses/medical/physician
https://live-dial-iowa-gov.pantheonsite.io/chronic-pain-and-end-life-training

(2) hours that address the current CDC prescribing guidelines, including chronic pain management, dosing recommendations, length of prescriptions, risk factors for abuse, and non-opioid on nonpharmacologic options;
ARNPs supervising fluoroscopy during the three-year renewal cycle must take CE to include initial and annual radiological safety courses.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dial.iowa.gov/licenses/medical/nursing-professional-midwifery/continuing-education/arnp-ce-requirements

(2) hours regarding the guidelines for prescribing opioids for pain management, as issued by the CDC and Prevention of the USDHHS, including recommendations on limitations on dosages and the length of prescriptions, risk factors for abuse, and nonopioid and nonpharmacologic therapy options.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dial.iowa.gov/licenses/medical/physician-assistants#renewal"

(2) hours of at least one of the following content requirements:
(A) Acute or Pain Management management;
(B) the appropriate prescribing of opioids; or
(C) the use of prescription drug monitoring programs.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
http://www.ksbha.org/main.shtml

No topic-specific CE required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://ksbn.kansas.gov/cnes/

(2) hours of at least one of the following content requirements:
(A) Acute or Pain Management management;
(B) the appropriate prescribing of opioids; or
(C) the use of prescription drug monitoring programs.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
http://www.ksbha.org/faq/faqlicensingpa.shtml

(3) hour domestic violence training course within 3 years of initial licensure, for primary care physicians;
(4.5) hours relating to the use of KASPER, pain management, addiction disorders, or a combination of two or more those (must be Board approved; for controlled substance prescribers);
(12) hours related to addiction medicine (for those authorized to prescribe or administer Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone; must be Board approved);
(1.5) hours on the recognition and prevention of pediatric abusive head trauma (one-time requirement within 5 years of licensure for pediatricians, radiologists, family practitioners, and emergency medicine and urgent care physicians; must be Board approved).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://kbml.ky.gov/cme/Pages/default.aspx

(5) pharmacology contact hours, and (1.5) of these must be in the dual subject of pharmacology and either pain management, or addiction disorders;
(4) hours on addiction disorders;
(3) hours on domestic violence, and elder abuse, neglect and exploitation on adult and child victims (within 3 years of licensure);
(1.5) hours on the recognition and prevention of pediatric abusive head trauma (within 3 years of licensure);
(2) hours on suicide prevention (within 3 years of licensure).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://kbn.ky.gov/continuing-education/Pages/Continuing-Education-Requirements.aspx

(12) hours related to addiction medicine (for those authorized to prescribe or administer Buprenorphine-Mono-Product or Buprenorphine-Combined-with-Naloxone; must be Board-approved);
(7.5) hours relating to: a. controlled substance diversion; b. pain management; c. addiction disorders; d. the use of KASPER; or e. any combination of two or more of these subjects (must be Board-approved);
(1.5) hours on the recognition and prevention of pediatric abusive head trauma (one-time requirement within the first 2 years of initial licensure; must be Board-approved);
(1) hour on human immunodeficiency virus and acquired immunodeficiency syndrome (one-time requirement within the first 2 years of initial licensure).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://apps.legislature.ky.gov/law/kar/titles/201/009/360/
https://kbml.ky.gov/ah/Pages/Physician-Assistant.aspx"

(3) hours of CME to include all 4 of the following topics: 1) best practices for the prescribing of CDS, 2) drug diversion training, 3) appropriate treatment for addiction, and 4) the treatment of chronic pain (one-time requirement for practitioners with a Controlled Dangerous Substance license; as of 1/1/2025, the only approved course is offered through the Board).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.lsbme.la.gov/content/board-approved-cme-courses-cds-requirements

(3) hours to include all 4 of the following topics: 1) best practices for the prescribing of CDS, 2) drug diversion training, 3) appropriate treatment for addiction, and 4) the treatment of chronic pain (one-time requirement for practitioners with a Controlled Dangerous Substance license; as of 1/1/2025, the only approved course is offered through the Board).

(6) contact hours of CE in pharmacotherapeutics in their advanced nursing role and population foci (annually).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.lsbn.state.la.us/continuing-education-2/

(3) hours of CME to include all 4 of the following topics: 1) best practices for the prescribing of CDS, 2) drug diversion training, 3) appropriate treatment for addiction, and 4) the treatment of chronic pain (one-time requirement for practitioners with a Controlled Dangerous Substance license; as of 1/1/2025, the only approved course is offered through the Board).  

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.lsbme.la.gov/content/board-approved-cme-courses-cds-requirements

(3) hours on the prescribing of opioid medication.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.maine.gov/md/licensure

(3) hours on the prescribing of opioid medication.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.maine.gov/boardofnursing/laws-rules/index.html (Ch. 21)

(3) hours on the prescribing of opioid medication.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.maine.gov/md/licensure

(2) hours on prescribing or dispensing of controlled substances (one-time requirement for controlled substance prescribers);
(2) hours on implicit bias (one-time requirement with first renewal after April 2022).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://health.maryland.gov/ocsa/Documents/CME%20Outreach%20FAQ.pdf
https://health.maryland.gov/mhhd/Pages/Implicit-Bias-Resources.aspx

(2) hours on prescribing or dispensing of controlled substances (one-time requirement for controlled substance prescribers);
(2) hours on implicit bias (one-time requirement with first renewal after April 2022).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://health.maryland.gov/ocsa/Documents/CME%20Outreach%20FAQ.pdf
https://health.maryland.gov/mhhd/Pages/Implicit-Bias-Resources.aspx

(2) hours on prescribing or dispensing of controlled substances (one-time requirement for controlled substance prescribers);
(2) hours on implicit bias (one-time requirement with first renewal after April 2022).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://health.maryland.gov/ocsa/Documents/CME%20Outreach%20FAQ.pdf
https://health.maryland.gov/mhhd/Pages/Implicit-Bias-Resources.aspx

(10) hours on Risk Management;
(2) hours on Implicit Bias (may also be applied toward Risk Management requirement);
(3) hours on Opioids and Pain Management (if the physician prescribes controlled substances; may also be applied toward Risk Management);
(2) hours on End-of-Life Issues (one-time requirement);
(2) hours on Board Regulations;
(3) hours on Proficiency in Electronic Health Records (one-time requirement);
(1) hour on Alzheimer's Disease and Related Dementias (one-time requirement for those who serve adult populations);
Training - Domestic Violence and Sexual Assault (one-time requirement);
Training - Recognizing and Reporting Suspected Child Abuse (one-time requirement).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.mass.gov/doc/borim-cme-requirements-pdf/download
https://www.mass.gov/info-details/renewal-requirement-for-alzheimers-disease-continuing-medical-education-cme

To renew your nursing license, The Board of Registration in Nursing requires all licensed nurses in Massachusetts to complete 15 contact hours.

To apply for prescriptive authority from MA Controlled Substance Registration (MCSR) and to renew your APRN authorization every two years, all prescribers must complete education relative to:
1. Effective pain management
2. The risks of abuse and addiction associated with opioid medication
3. Identification of patients at risk for substance use disorders
4. Counseling patients about the side effects, addictive nature and proper storage and disposal of prescription medications
5. Appropriate prescription quantities for prescription medications that have an increased risk of abuse
6. Opioid antagonists, overdose prevention treatments and instances in which a patient may be advised on both the use of and ways to access opioid antagonists and overdose prevention treatments.
These prescriber training requirements are in accordance with Massachusetts General Law, Chapter 94, Section 18. A minimum number of contact hours to comply with this education requirement is not specified.

Training on Domestic Violence and Sexual Assault (one-time requirement).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.mass.gov/info-details/mandatory-continuing-education-for-nurses
https://www.mass.gov/service-details/learn-more-about-prescriptive-authority-requirements-and-practice-guidelines

Board laws and regulations, as defined in 263 CMR 3.05, requires completion of 100 contact hours with a minimum of 40 in Category 1 of continuing education for the current registration period.

Physician assistants who prescribe controlled substances must complete CMEs in the following topics:
1. Effective pain management
2. The risks of abuse and addiction associated with opioid medication
3. Identification of patients at risk for substance use disorders
4. Counseling patients about the side effects, addictive nature and proper storage and disposal of prescription medications
5. Appropriate prescription quantities for prescription medications that have an increased risk of abuse
6. Opioid antagonists, overdose prevention treatments and instances in which a patient may be advised on both the use of and ways to access opioid antagonists and overdose prevention treatments.
These prescriber training requirements are in accordance with Massachusetts General Law, Chapter 94, Section 18. A minimum number of contact hours to comply with this education requirement is not specified.

Training on Domestic Violence and Sexual Assault (one-time requirement).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.mass.gov/how-to/renew-your-physician-assistant-license

(3) hours on pain and symptom management;
(1) hour on medical ethics;
Opioid and other controlled substances awareness that meets standards of the Board of Pharmacy Controlled Substances Administrative Rules (one-time training for controlled substance prescribers);
Human trafficking (one-time requirement);
Implicit bias training, to include pre/post-test (renewals - (1) hour per year; initial license - (2) hour within the 5 years immediately preceding licensure).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.michigan.gov/lara/bureau-list/bpl/health/hp-lic-health-prof/medical#Licensing_Information
https://www.msms.org/About-MSMS/News-Media/medical-license-renewal-what-you-need-to-know

(2) hours on pain and symptom management;

Opioid and other controlled substances awareness that meets standards of the Board of Pharmacy Controlled Substances Administrative Rules (one-time training for controlled substance prescribers);
Human trafficking (one-time requirement);
Implicit bias training (renewals: 1 hour per year; initial license: 2 hour within the 5 years immediately preceding licensure).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.michigan.gov/lara/bureau-list/bpl/health/hp-lic-health-prof/nursing

Opioid and other controlled substances awareness that meets standards of the Board of Pharmacy Controlled Substances Administrative Rules (one-time training for controlled substance prescribers);
Human trafficking (one-time requirement);
Implicit bias training (renewals: 1 hour per year; initial license: 2 hour within the 5 years immediately preceding licensure).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.michigan.gov/lara/0,4601,7-154-72600_72603_27529_27550---,00.html

No topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://mn.gov/boards/medical-practice/licensing/continuing-ed/

No topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://mn.gov/boards/nursing/licensure/continuing-ed/
https://mn.gov/boards/nursing/advanced-practice/advanced-practice-registered-nurse-(aprn)-licensure-general-information/

No topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://mn.gov/boards/medical-practice/licensing/continuing-ed/

(5) hours related to prescribing of controlled substances (every two years, for those with DEA license).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.msbml.ms.gov/Renewals

(5) hours related to prescribing of controlled substance (irrespective of controlled substance prescriptive authority).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.msbn.ms.gov/licensure/advanced-practice-registered-nurse

5) hours of CME related to prescribing of controlled substances (every two years, for those authorized to prescribe controlled substances).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.msbml.ms.gov/Renewals

No topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://pr.mo.gov/physiciansandsurgeons-forms.asp

No topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://pr.mo.gov/nursing.asp
https://www.sos.mo.gov/adrules/csr/current/20csr/20csr.asp#20-2200

No topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://pr.mo.gov/physicianassistants.asp

No topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://boards.bsd.dli.mt.gov/medical-examiners/

No topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://boards.bsd.dli.mt.gov/nursing/continuing-education

No topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://boards.bsd.dli.mt.gov/medical-examiners/

(3) hours on the subject of opioids, and .5 hours of the 3 hours are required to be on the subject of the Prescription Drug Monitoring Program (PDMP) (for all professionals who prescribe controlled substances). CE may include, but is not limited to, education regarding prescribing and administering opiates; the risks and indicators regarding development of addiction to opiates; and emergency opiate situations.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dhhs.ne.gov/licensure/Pages/Medicine-and-Surgery.aspx

(3) hours on the subject of opioids, and .5 hours of the 3 hours are required to be on the subject of the Prescription Drug Monitoring Program (PDMP) (for all professionals who prescribe controlled substances). CE may include, but is not limited to, education regarding prescribing and administering opiates; the risks and indicators regarding development of addiction to opiates; and emergency opiate situations.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dhhs.ne.gov/licensure/Pages/Nurse-Licensing.aspx

(3) hours on the subject of opioids, and .5 hours of the 3 hours are required to be on the subject of the Prescription Drug Monitoring Program (PDMP) (for all professionals who prescribe controlled substances). CE may include, but is not limited to, education regarding prescribing and administering opiates; the risks and indicators regarding development of addiction to opiates; and emergency opiate situations.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dhhs.ne.gov/licensure/Pages/Medicine-and-Surgery.aspx

(2) hours on misuse and abuse of controlled substances/prescribing of opioids; or addiction (for physicians registered to dispense controlled substances);
(2) hours in ethics, pain management, and/or addiction care;
(2) hours every 4 years on suicide detection, intervention and prevention;
(2) hours on the screening, brief intervention & referral to treatment (SBIRT) (one time requirement to be completed on or before the 2025 renewal period);
(4) hours on bioterrorism, relating to the medical consequences of an act of terrorism that involves the use of a weapon of mass destruction;
(2) hours on cultural competency and diversity, equity, and inclusion (psychiatrists only);
(2) hours of training in the stigma, discrimination and unrecognized bias toward persons who have acquired or are at high risk of acquiring human immunodeficiency virus (required for providers of health care who provides or supervises the provision of emergency medical care or primary care in a hospital, one time requirement beginning with renewals on/after January 2024).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://medboard.nv.gov/Licensees/CE/

(2) hours on misuse and abuse of controlled substances/prescribing of opioids; or addiction (for those registered to dispense controlled substances);
(2) hours every 4 years on suicide detection, intervention and prevention;
(2) hours on the screening, brief intervention & referral to treatment (SBIRT) (one time requirement to be completed on or before the 2025 renewal period);
(4) hours relating to the medical consequences of an act of terrorism that involves the use of a weapon of mass destruction (one-time requirement);
(4) hours on cultural competency, diversity, equity, and inclusion;
(2) hours of training in the stigma, discrimination and unrecognized bias toward persons who have acquired or are at high risk of acquiring human immunodeficiency virus (required for providers of health care who provides or supervises the provision of emergency medical care or primary care in a hospital, one time requirement beginning with renewals on/after January 2024).
The Board encourages each licensee who treat or care for persons who are more than 60 years of age to participate in education in geriatrics and gerontology.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://nevadanursingboard.org/continuing-education/

(2) hours on misuse and abuse of controlled substances/prescribing of opioids; or addiction (for those who are registered to dispense controlled substances);
(2) hours in ethics, pain management, and/or addiction care;
(2) hours every 4 years on suicide detection, intervention and prevention;
(2) hours on the screening, brief intervention & referral to treatment (SBIRT) (one time requirement to be completed on or before the 2025 renewal period);
(4) hours on bioterrorism, relating to the medical consequences of an act of terrorism that involves the use of a weapon of mass destruction;
(2) hours on cultural competency and diversity, equity, and inclusion (for PAs practicing under supervision of a psychiatrist);
(2) hours of training in the stigma, discrimination and unrecognized bias toward persons who have acquired or are at high risk of acquiring human immunodeficiency virus (required for providers of health care who provides or supervises the provision of emergency medical care or primary care in a hospital, one time requirement beginning with renewals on/after January 2024).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://medboard.nv.gov/Licensees/CE/

(3) hours in the area of pain management and addiction disorder or a combination (all prescribers required to register with the program who possess a U.S. DEA license number).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.oplc.nh.gov/board-medicine-opioid-prescribing

(3) hours in the area of pain management and addiction disorder or a combination (all prescribers required to register with the program who possess a U.S. DEA license number).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.oplc.nh.gov/board-nurses-education-and-training

(3) hours in the area of pain management and addiction disorder or a combination (all prescribers required to register with the program who possess a U.S. DEA license number).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.oplc.nh.gov/board-medicine-opioid-prescribing

(2) hours on end-of life care;
(1) hour on prescription opioid drugs, including responsible prescribing practices, alternatives to opioids for managing and treating pain, and the risks and signs of opioid abuse, addiction, and diversion.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.njconsumeraffairs.gov/bme/Pages/continuingeducation.aspx

(1) hour on prescription opioid drugs, including responsible prescribing practices, alternatives to opioids for managing and treating pain, and the risks and signs of opioid abuse, addiction, and diversion.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.njconsumeraffairs.gov/nur/Pages/Continuing-Education-FAQ.aspx

(1) hour on prescription opioid drugs, including responsible prescribing practices, alternatives to opioids for managing and treating pain, and the risks and signs of opioid abuse, addiction, and diversion.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.njconsumeraffairs.gov/pa/Pages/FAQ.aspx

MD:
(5) hours of pain management/prescribing of controlled substances CME; should include a review of NM Medical Board Rule 16.10.14 NMAC on pain management; an understanding of the pharmacology and risks of controlled substances, a basic awareness of the problems of abuse, addiction and diversion, and awareness of state and federal regulations for the prescription of controlled substances (for all New Mexico medical board licensees who hold a federal DEA registration and a New Mexico controlled substances registration).
(1) hour of CME must be earned by reviewing the New Mexico Medical Practice Act and these board rules.

DO:
(6) CME credits in pain management (for those who possess a NM controlled substance license).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.nmmb.state.nm.us/cme.html; https://www.rld.nm.gov/uploads/files/16%2017%205%20NMAC%20RULE%20FOR%20WEBSITE.pdf
https://www.rld.nm.gov/uploads/files/16%2017%205%20NMAC%20RULE%20FOR%20WEBSITE.pdf

(5) hours of non-cancer pain management CE (to include a review of rules 16.12.9 NMAC for management of non-cancer pain, an understanding of the pharmacology and risks of controlled substances, a basic awareness of the problems of abuse, addiction and diversion, and awareness of state and federal regulations for the prescription of controlled substances).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.bon.nm.gov/ceu/

(3) hours of pain management with controlled substances CME, to include all of the following educational elements:
1) an understanding of the pharmacology and risks of controlled substances;
2) a basic awareness of the problems of abuse, addiction and diversion;
3) awareness of state and federal regulations for the prescription of controlled substances;
4) management of the treatment of pain; and
5) courses may also include a review of this rule 16.10.14 NMAC.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.nmmb.state.nm.us/cme.html

(3) hours in pain management, palliative care, and addiction (for controlled substances prescribers; required every three years);
(2) hours of child abuse training (one-time requirement for initial license; must be by an approved provider);
Infection control training (every 4 years; must be by an approved provider).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.op.nysed.gov/physicians/mandated-training-medicine

(3) hours in pain management, palliative care, and addiction (for controlled substances prescribers; required every three years);
(2) hours of child abuse training (one-time requirement for initial license; must be by an approved provider);
Infection control training (every 4 years; must be by an approved provider).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.op.nysed.gov/professions/nurse-practitioners/certification-requirements
https://www.op.nysed.gov/about/training-continuing-education

(3) hours in pain management, palliative care, and addiction (for controlled substances prescribers; required every three years); Infection control training (every 4 years; must be by an approved provider).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.op.nysed.gov/mandated-training-physician-assistants

(3) hours of CME designed specifically to address controlled substance prescribing practices (for physicians who prescribe controlled substances, except those holding a residency training license). Topics shall include instruction on controlled substance prescribing practices, recognizing signs of the abuse or misuse of controlled substances, and controlled substance prescribing for pain management.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.ncmedboard.org/resources-information/faqs/continuing_medical_education_cme
https://www.ncmedboard.org/resources-information/faqs/controlled-substances-cme-requirement

(50) contact hours required every two years, to include:
(1) hour of opioids and controlled Substances education (for those NPs who prescribe controlled substances). Topics must address substance prescribing practices, signs of the abuse or misuse of controlled substances, and controlled substance prescribing for chronic pain management.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.ncbon.com/aprn-continuing-competence

(2) hours of controlled substances CME during each two-year CME cycle (for licensees who prescribe controlled substances). Topics must address instruction on controlled substance prescribing practices, recognizing signs of the abuse or misuse of controlled substances, and controlled substance prescribing for chronic pain management.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.ncmedboard.org/resources-information/faqs/controlled-substances-cme-requirement

No state topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.ndbom.org/practitioners/cme.asp

No state topic-specific CE required. 15 contact hours in pharmacology related to the scope of practice are required for renewal of prescriptive authority.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.ndbon.org/FAQ/Renewal-ApprovedCE.asp

No state topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.ndbom.org/practitioners/cme.asp

(1) hour on a licensee’s duty to report to SMB of Ohio;
(20) hours in pain medicine (for Physicians who own and/or practice at a pain management clinic).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://med.ohio.gov/apply-and-renew/licenses-and-certifications/01-physician-(md,-do,-dpm)

The Ohio Board of Nursing does not require any topic-specific CE.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://nursing.ohio.gov/continuing-education-and-pre-licensure/continuing-education/ce-requirements-for-renewal

The State Medical Board in Ohio does not require any topic-specific CME for Physician Assistants.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://med.ohio.gov/apply-and-renew/licenses-and-certifications/04-physician-assistant-(pa)

(1) hour in pain management or one (1) hour in opioid use or addiction.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.okmedicalboard.org/cme

(2) hours in pain management or two (2) hours in opioid use or addiction (for CNP, CNM, CNS Prescriptive Authority).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://oklahoma.gov/nursing/practice.html

(1) hour on substance abuse.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.okmedicalboard.org/physician_assistants#ce-requirements

(1) hour of cultural competency continuing education every year.

All actively licensed Board licensees are required to complete the Oregon Pain Management Commission's (OPMC) continuing education course, at initial licensure and every two years.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.oregon.gov/omb/Topics-of-Interest/Pages/Continuing-Education.aspx

(2) hours of cultural competency education.

All actively licensed Board licensees are required to complete the Oregon Pain Management Commission's (OPMC) continuing education course, at initial licensure and every renewal thereafter.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.oregon.gov/osbn/Pages/index.aspx"

(1) hour of cultural competency continuing education every year.

All actively licensed Board licensees are required to complete the Oregon Pain Management Commission's (OPMC) continuing education course Changing the Conversation About Pain, at initial licensure and every two years.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.oregon.gov/omb/Topics-of-Interest/Pages/Continuing-Education.aspx

(2) hours in pain management, addiction or opioid prescribing/dispensing;
(12) hours in patient safety or risk management;
Child abuse recognition and reporting (must be approved by state DHS; 2 hours for initial license and 3 hours for renewal).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.dos.pa.gov/ProfessionalLicensing/BoardsCommissions/Medicine/Pages/CME-Requirements.aspx

(2) hours in pain management or identification of addiction;
(2) hours in opioid prescribing/dispensing;
Child abuse recognition and reporting (must be approved by state DHS; 2 hours for initial license and 3 hours for renewal).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.dos.pa.gov/ProfessionalLicensing/BoardsCommissions/Nursing/Pages/Renewal-Information.aspx

(2) hours in pain management or identification of addiction (initial license);
(2) hours in opioid prescribing/dispensing (initial license);
(2) hours in pain management, identification of addiction, or opioid prescribing/dispensing (renewals);
Child abuse recognition and reporting (must be approved by state DHS; 2 hours for initial license and 3 hours for renewal).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.dos.pa.gov/ProfessionalLicensing/BoardsCommissions/Medicine/Pages/CME-Requirements.aspx"

(1) hour (per career) of CME training regarding Alzheimer’s disease;
(8) hours in any or all of the following topics: a. Appropriate prescribing of opioids for pain; b. Pharmacology; c. Adverse events; d. Potential for dependence; e. Tolerance; f. Addiction; g. Alternatives to opioids for pain management. h. Allthough no one specific course is required, the Drug Addiction Treatment Act of 2000 (DATA 2000) waiver training course qualifies for the above requirement (required for any practitioner who prescribes a Schedule 2 opioid).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.health.ri.gov/licenses/detail.php?id=200

(1) hour (per career) of CEU training regarding Alzheimer’s disease; (2) hours of CE about substance abuse; (8) hours in any or all of the following topics: a. Appropriate prescribing of opioids for pain; b. Pharmacology; c. Adverse events; d. Potential for dependence; e. Tolerance; f. Addiction; g. Alternatives to opioids for pain management. h. Although no one specific course is required, the Drug Addiction Treatment Act of 2000 (DATA 2000) waiver training course qualifies for the above requirement (required for any practitioner who prescribes a Schedule 2 opioid).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
http://www.health.ri.gov/licenses/detail.php?id=231

(8) hours in any or all of the following topics: a. Appropriate prescribing of opioids for pain; b. Pharmacology; c. Adverse events; d. Potential for dependence; e. Tolerance; f. Addiction; g. Alternatives to opioids for pain management. h. Allthough no one specific course is required, the Drug Addiction Treatment Act of 2000 (DATA 2000) waiver training course qualifies for the above requirement (required for any practitioner who prescribes a Schedule 2 opioid).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://health.ri.gov/licenses/detail.php?id=237

(2) hours on prescribing and monitoring controlled substances listed in Schedules II, III, and IV.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://llr.sc.gov/med/ce.aspx

(15) hours in controlled substances (for NP, CNM, or CNS who applies for prescriptive authority);
(2) hours on prescribing controlled substances (for NP, CNM, or CNS renewal of controlled substance prescriptive authority).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.scstatehouse.gov/code/t40c033.php

(4) hours on prescribing and monitoring controlled substances listed in Schedules II, III, and IV (for controlled substance prescriptive authority).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://llr.sc.gov/med/ce.aspx

No state topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://sdbmoe.gov/professions-physicians/professions-physicians-physician-license-md-do/

No state topic-specific CE required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.sdbon.org/

No state topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://sdbmoe.gov/professions-physician-assistant-pa/

(2) hours on controlled substance prescribing practices, to include instruction in the Tennessee Department of Health’s treatment guidelines on opioids, benzodiazepines, barbiturates and carisoprodol, and may include such other topics as medication addiction or risk management tools.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.tn.gov/health/health-program-areas/health-professional-boards/me-board/me-board/continuing-education.html

(2) hours on controlled substance prescribing practices, to include instruction in the Tennessee Department of Health’s treatment guidelines on opioids, benzodiazepines, barbiturates, and carisoprodol, and may include such other topics as medicine addiction and risk management tools (for those with prescriptive authority and are holders of a Certificate of Fitness).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.tn.gov/health/health-program-areas/health-professional-boards/nursing-board/nursing-board/continuing-education.html

(2) hours on controlled substance prescribing, which must include instruction in the Department’s treatment guidelines (i.e., Tennessee Pain Management Guidelines) on opioids, benzodiazepines, barbiturates, and carisoprodol and may include topics such as medicine addiction, risk management tools, and other topics approved by the Committee (applies to all licensees, regardless of whether they possess a DEA registration).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.tn.gov/health/health-program-areas/health-professional-boards/pa-board/pa-board/continuing-education.html

(2) hours in medical ethics and/or professional responsibility;
(1) hour in human trafficking prevention;
(2) hours in safe and effective pain management (best practices, alternative treatment options, safe opioid/controlled substances prescribing and monitoring);
One course in human trafficking prevention approved by the Texas Health and Human Services Commission.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
http://www.tmb.state.tx.us/page/resources-cme-for-md-dos

(2) hours in nursing jurisprudence and ethics (to include information related to the Texas Nursing Practice Act, Texas BON Rules, Texas BON Position Statements, principles of nursing ethics and professional boundaries);
(2) hours relating to older adult or geriatric population (if practice includes older adult or geriatric populations);
One course in human trafficking prevention approved by the Texas Health and Human Services Commission.

For those with prescriptive authority:
(5) additional hours in pharmacotherapeutics;
(2) hours related to approved procedures of prescribing and monitoring controlled substances (one-time requirement, within 1 year of initial licensure);
(4) hours (or 2 hours annually) in safe and effective pain management related to the prescription of opioids and other controlled substances, including reasonable standards of care, identification of drug-seeking behavior in patients, and effectively communicating with patients regarding the prescription of an opioid or other controlled substance.

Any APRN whose practice includes the treatment of tick-borne diseases is encouraged to participate in continuing education relating to the treatment of tick-borne diseases.

Any nurse who is employed in an emergency room (ER) setting must complete at least 2 contact hours of CNE relevant to forensic evidence collection and age- or population-specific nursing interventions that may be required by other laws and/or are necessary in order to assure evidence collection that meets requirements under the Government Code §420.031 regarding use of an Attorney General-approved evidence collection kit and protocol (one-time requirement).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.bon.texas.gov/education_continuing_education.asp.html#Z

(2) hours in safe and effective pain management (best practices, alternative treatment options, safe opioid/controlled substances prescribing and monitoring).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.tmb.state.tx.us/page/resources-cmd-pa

(3.5) hours in SBIRT-training each licensure cycle (for controlled substance prescribers).

Complete at least one of the required online suicide prevention trainings (see link below for qualified training).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dopl.utah.gov/physician-and-surgeon/renew-a-license/

(3.5) hours in SBIRT-training each licensure cycle (for controlled substance prescribers);
(.5) hour from DOPL's online controlled substance tutorial (for controlled substance prescribers).

Complete at least one of the required online suicide prevention trainings (see link below for qualified training).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dopl.utah.gov/nursing/

(3.5) hours in SBIRT-training each licensure cycle (for controlled substance prescribers);
(.5) hour from DOPL's online controlled substance tutorial (for controlled substance prescribers).

Complete at least one of the required online suicide prevention trainings (see link below for qualified training).

8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dopl.utah.gov/physician-assistant/renew-a-license/

(1) hours on the topics of hospice, palliative care, or pain management services.
(2) hours on controlled substances prescribing. The following topics must be covered, as required by Vermont law: abuse and diversion, safe use, and appropriate storage and disposal of controlled substances; the appropriate use of the Vermont Prescription Monitoring System; risk assessment for abuse or addiction; pharmacological and nonpharmacological alternatives to opioids for managing pain; medication tapering and cessation of the use of controlled substances; and relevant State and federal laws and regulations concerning the prescription of opioid controlled substances.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://www.healthvermont.gov/sites/default/files/documents/pdf/BMP_CME_Excerpt_In_Rules.pdf

(2) hours on controlled substances prescribing. The following topics must be covered, as required by Vermont law: abuse and diversion, safe use, and appropriate storage and disposal of controlled substances; the appropriate use of the Vermont Prescription Monitoring System; risk assessment for abuse or addiction; pharmacological and nonpharmacological alternatives to opioids for managing pain; medication tapering and cessation of the use of controlled substances; and relevant State and federal laws and regulations concerning the prescription of opioid controlled substances.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://legislature.vermont.gov/statutes/chapter/26/028
https://sos.vermont.gov/media/5dep2imt/nursing-admin-rules_05_11_2023.pdf

(2) hours on controlled substances prescribing. The following topics must be covered, as required by Vermont law: abuse and diversion, safe use, and appropriate storage and disposal of controlled substances; the appropriate use of the Vermont Prescription Monitoring System; risk assessment for abuse or addiction; pharmacological and nonpharmacological alternatives to opioids for managing pain; medication tapering and cessation of the use of controlled substances; and relevant State and federal laws and regulations concerning the prescription of opioid controlled substances.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
www.healthvermont.gov/BMP_Renewals_CME_Excerpt_of_Rules_for_PAs.pdf

No state topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
http://www.dhp.virginia.gov/Boards/Medicine/PractitionerResources/ContinuingEducation/Medicine/

No state topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
www.dhp.virginia.gov/AdvancedPracticeRegisteredNurse/

No state topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
http://www.dhp.virginia.gov/Boards/Medicine/PractitionerResources/ContinuingEducation/Medicine/

(1) hour on opioid prescribing (one-time requirement);
(2) hours on health equity (every four years);
(6) hours on suicide prevention training (one-time requirement of a board-approved course).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://wmc.wa.gov/education/continuing-medical-education-cme-requirements;
https://app.leg.wa.gov/rcw/default.aspx?cite=43.70.613;
https://app.leg.wa.gov/wac/default.aspx?cite=246-919-875;
https://app.leg.wa.gov/wac/default.aspx?cite=246-853-065;
https://app.leg.wa.gov/rcw/default.aspx?cite=43.70.442

(1) hour on opioid prescribing (one-time requirement);
(2) hours of health equity CE (per renewal period);
(6) hours on suicide prevention training (one-time requirement of a board-approved course, to be completed by the end of the first full year of practice).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://nursing.wa.gov/licensing/maintain-license/continuing-competency

(1) hour on opioid prescribing (one-time requirement);
(2) hours on health equity (every four years);
(6) hours on suicide prevention training (one-time requirement of a board-approved course).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://app.leg.wa.gov/WAC/default.aspx?cite=246-918-180;
https://app.leg.wa.gov/WAC/default.aspx?cite=246-918-825;
https://app.leg.wa.gov/rcw/default.aspx?cite=43.70.613;
https://app.leg.wa.gov/rcw/default.aspx?cite=43.70.442

(3) hours of Board-approved CME in drug diversion and best practices prescribing of controlled substances during each reporting period (for physicians who have prescribed, administered, or dispensed any controlled substance in any jurisdiction in the two year license cycle preceding renewal).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://wvbom.wv.gov/Cont_Med_Education.asp

(3) hours of CE in drug diversion training, best-practice prescribing of controlled substances training and training on prescribing and administration of an opioid antagonist (if you prescribe, administer or dispense controlled substances; required within 1 year of receiving initial license from the Board).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://wvrnboard.wv.gov/education/Pages/default.aspx#edrequirements

(3) hours of Board-approved CME in drug diversion and best practices prescribing of controlled substances during each reporting period (for physician assistants who have prescribed, administered, or dispensed any controlled substance in any jurisdiction in the two year license cycle preceding renewal).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://wvbom.wv.gov/PACME2018.asp

(2) hours on prescribing opioids and other controlled substances.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dsps.wi.gov/Pages/Professions/Physician/CE.aspx
https://docs.legis.wisconsin.gov/code/admin_code/med/13

(16) hours in clinical pharmacology or therapeutics relevant to advance practice nurse prescriber's area of practice, to include:
(2) contact hours in responsible prescribing of controlled substances.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dsps.wi.gov/Pages/RulesStatutes/Nursing.aspx
https://docs.legis.wisconsin.gov/code/admin_code/n/8.pdf

No state topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://dsps.wi.gov/Pages/Professions/PhysicianAssistant/Default.aspx

(1) hour of CME related to responsible prescribing of controlled substances or treatment of substance abuse disorders in the preceding two (2) years (for physicians holding a Wyoming controlled substance registration).

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://wyomedboard.wyo.gov/physicians/renew-license

No state topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://wsbn.wyo.gov/licensing

No state topic-specific CME required.

(8) hours on treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all FDA-approved drugs for the treatment of a substance use disorder. This is a one-time requirement for all DEA-registered practitioners (with the exception of DVM-only license holders), beginning with DEA initial or renewal registrations starting June 27, 2023.

For more information:
https://wyomedboard.wyo.gov/physician-assistants